Pempidine

Pempidine

SCHEMBL933339

CN1C(C)(C)CCCC1(C)C.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Pempidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 1.00
NFKB1 P19838 1/20 1.00
CYP2C19 P33261 1/20 1.00
BLM P54132 3/20 0.32
LMNA P02545 2/20 0.32
CYP3A4 P08684 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PMP22 Q01453 1/20 0.32
FFAR3 O14843 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALOX15 P16050 1/20 0.31
MAPT P10636 1/20 0.30
CYP2D6 P10635 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pempidine SCHEMBL987199 0.82 TSHR (0.69) TSHRNFKB1CYP2C19FFAR3
Pempidine SCHEMBL4798468 0.76 TSHR (0.58) TSHRNFKB1CYP2C19
Pempidine SCHEMBL217663 0.76 TSHR (0.58) TSHRNFKB1CYP2C19
Pempidine SCHEMBL25374670 0.75 TSHR (0.60) TSHRNFKB1CYP2C19FFAR3SMN1; SMN2
Pempidine SCHEMBL22408827 0.75 TSHR (0.60) TSHRNFKB1CYP2C19LMNAFFAR3
Pempidine SCHEMBL28926027 0.74 TSHR (0.58) TSHRNFKB1CYP2C19
Pempidine SCHEMBL988172 0.74 TSHR (0.56) TSHRNFKB1CYP2C19
Pempidine SCHEMBL5050688 0.74 TSHR (0.56) TSHRNFKB1CYP2C19
Pempidine SCHEMBL17292879 0.73 TSHR (0.57) TSHRNFKB1CYP2C19
Pempidine SCHEMBL986676 0.73 TSHR (0.57) TSHRNFKB1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120030456-A Data cleaning and fault diagnosis method for traction mechanism of quay crane trolley 频率探索智能科技江苏有限公司 2025-05-23 CN claimed
CN-120014124-A Real-time interaction-oriented face feature diversification synthesis self-adaptive digital human system 联通沃音乐文化有限公司 2025-05-16 CN claimed
CN-119763665-A Gene regulation and control network inference method and system based on graph representation learning 江南大学 2025-04-04 CN claimed
CN-117935925-A Antigen-antibody binding affinity prediction method and system based on ensemble learning 华中科技大学 2024-04-26 CN claimed
CN-117453669-A Data recovery method and system for liquid level monitoring sequence 中国电建集团华东勘测设计研究院有限公司 2024-01-26 CN claimed
WO-2023229993-A1 OPHTHALMIC FORMULATION CAPABLE OF DELIVERING METFORMIN TO CHOROID RPE AND RETINA CURATIVE BIOTECHNOLOGY, INC. (US) 2023-11-30 WO claimed
EP-4027985-A1 DRUGGABLE TARGET TO TREAT RETINAL DEGENERATION The United States of America, as represented by The Secretary, Department of Health and Human Services (US) 2022-07-20 EP claimed
WO-2021050980-A1 DRUGGABLE TARGET TO TREAT RETINAL DEGENERATION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2021-03-18 WO claimed
US-20100029654-A1 CARDIOVASCULAR COMPOSITIONS AND USE OF THE SAME FOR THE TREATMENT OF ALZHEIMER'S DISEASE MOUNT SINAI SCHOOL OF MEDICINE 2010-02-04 US claimed
EP-2007385-A2 CARDIOVASCULAR COMPOSITION AND USE THE SAME FOR THE TREATMENT OF ALZHEIMERS DISEASE Mount Sinai School of Medicine (US) 2008-12-31 EP claimed
WO-2007112288-A2 CARDIOVASCULAR COMPOSITION AND USE THE SAME FOR THE TREATMENT OF ALZHEIMERS DISEASE MOUNT SINAI SCHOOL OF MEDICINE (US) 2007-10-04 WO claimed
US-20040093951-A1 Magnetoelastic pressure sensor VISTEON GLOBAL TECHNOLOGIES, INC. 2004-05-20 US claimed
EP-4680243-A1 METHODS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION The United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2026-01-21 EP disclosed
US-20250339496-A1 SYSTEMS AND METHODS FOR SYMPATHETIC CARDIOPULMONARY NEUROMODULATION TULAVI THERAPEUTICS INC (US) 2025-11-06 US disclosed
EP-3288626-B1 SUBSTANCES AND COMPOSITIONS FOR USE IN BLOCKING NERVE REGENERATION REFLEX MEDICAL INC (US) 2025-10-29 EP disclosed
US-20250288728-A1 SYSTEMS AND METHODS FOR GEL-BASED NEUROMODULATION TULAVI THERAPEUTICS INC (US) 2025-09-18 US disclosed
US-20070043154-A1 Resin composition excellent in stability to face impact ASAHI KASEI CHEMICALS CORPORATION (JP) 2007-02-22 US disclosed
EP-1666533-A1 RESIN COMPOSITION EXCELLENT IN STABILITY TO FACE IMPACT Asahi Kasei Chemicals Corporation (JP) 2006-06-07 EP disclosed
US-20040093951-A1 Magnetoelastic pressure sensor VISTEON GLOBAL TECHNOLOGIES, INC. 2004-05-20 US disclosed
US-4341974-A Piezoelectric crystal element for use in force, pressure and acceleration transducers KISTLER INSTRUMENTE AG (CH) 1982-07-27 US disclosed